(+/-)5-HEPE
|
- $117 - $931
- Product name: (+/-)5-HEPE
- CAS: 83952-40-3
- MF: C20H30O3
- MW: 318.45
- EINECS:
- MDL Number:MFCD00171437
- Synonyms:(+/-)5-HEPE;(+/-)-5-HYDROXY-6E,8Z,11Z,14Z,17Z-EICOSAPENTAENOIC ACID;(+/-)5-HYDROXYEICOSA-6E,8Z,11Z,14Z,17Z-PENTAENOIC ACID;5-hydroxy-6,8,11,14,17-eicosapentaenoic acid;FTAGQROYQYQRHF-FCWZHQICSA-N;6,8,11,14,17-Eicosapentaenoic acid, 5-hydroxy-, (6E,8Z,11Z,14Z,17Z)-;5-Hydroxy-6(E),8(Z),11(Z),14(Z),17(Z)-EPA
4 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 25μg
- 50μg
- 100μg
- 250μg
- ManufacturerCayman Chemical
- Product number32200
- Product description(±)5-HEPE ≥97%
- Packaging25μg
- Price$117
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number32200
- Product description(±)5-HEPE ≥97%
- Packaging50μg
- Price$222
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number32200
- Product description(±)5-HEPE ≥97%
- Packaging100μg
- Price$419
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number32200
- Product description(±)5-HEPE ≥97%
- Packaging250μg
- Price$931
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 32200 | (±)5-HEPE ≥97% | 25μg | $117 | 2024-03-01 | Buy |
| Cayman Chemical | 32200 | (±)5-HEPE ≥97% | 50μg | $222 | 2024-03-01 | Buy |
| Cayman Chemical | 32200 | (±)5-HEPE ≥97% | 100μg | $419 | 2024-03-01 | Buy |
| Cayman Chemical | 32200 | (±)5-HEPE ≥97% | 250μg | $931 | 2024-03-01 | Buy |
Properties
Boiling point :488.0±45.0 °C(Predicted)
Density :0.997±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :0.1 M Na2CO3: 2 mg/ml; DMF: Miscible; DMSO: Miscible; Ethanol: Miscible; PBS pH 7.2: 0.8 mg/ml
form :Clear to light-yellow liquid.
pka :4.67±0.10(Predicted)
Density :0.997±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :0.1 M Na2CO3: 2 mg/ml; DMF: Miscible; DMSO: Miscible; Ethanol: Miscible; PBS pH 7.2: 0.8 mg/ml
form :Clear to light-yellow liquid.
pka :4.67±0.10(Predicted)
Safety Information
| Symbol(GHS): |
![]()
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
(±)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE. The biological activity of (±)5-HEPE is likely mediated by one of the individual isomers, most commonly the 5(S) isomer in mammalian systems. EPA can be metabolized to 5-HEPE in human and bovine neutrophils, and human eosinophils, which is further metabolized to 5-oxoEPE and LTB5. The 5-series metabolites of EPA, namely 5-HEPE, 5-oxoEPE, and LTB5, have significantly decreased biological effects compared to the arachidonic acid-derived metabolites.Suppliers and manufacturers
Yichang Zhongyitai Trading Co., Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Shanghai Hongye Biotechnology Co. Ltd
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
MedBioPharmaceutical Technology Inc
TargetMol Chemicals Inc.
SHANGHAI ZZBIO CO., LTD.
Hubei Danding Pharmaceutical Technology Co., Ltd
Cayman Chemical Company





